Home
Conditions
Neuroendocrine Tumors

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,766 public trials 495 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Active, Not Recruiting

Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma

NCT03543969

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +13 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Active, Not Recruiting

Diet and Immune Effects Trial: DIET- A Randomized Double Blinded Dietary Intervention Study in Patients With Metastatic Melanoma Receiving Immunotherapy

NCT04645680

Conditions: Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Eye Diseases, +23 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Optimization of Immunotherapy Treatment for Advanced Melanoma in the Context of the Public Brazilian Health System (OTIMAS)

NCT07376317

Conditions: Cutaneous Melanoma, Melanoma, Melanoma Metastatic, +13 more
Locations: ICESP São Paulo, Brazil

View Trial Details

Active, Not Recruiting

UCDCC#272: IL-2, Radiotherapy, and Pembrolizumab in Patients Refractory to Checkpoint Blockade

NCT03474497

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +37 more
Locations: UC Davis Medical Center Sacramento, California, United States

University of California Davis Medical Center Sacramento, California, United States

View Trial Details

Active, Not Recruiting

Proton Pencil Beam Scanning GRID for Treatment of Bulky Tumors

NCT05121545

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +11 more
Locations: Sibley Memorial Hospital Washington D.C., District of Columbia, United States

View Trial Details

Active, Not Recruiting

Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy

NCT02432963

Conditions: Adenocarcinoma, Adult Solid Neoplasm, Bladder Carcinoma, +74 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, Not Recruiting

Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors.

NCT03891953

Conditions: Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +33 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

Sarah Cannon Research Institute Nashville, Tennessee, United States

Novartis Investigative Site Dresden, Saxony, Germany

View Trial Details

Active, Not Recruiting

A Randomised Phase II Study of Roginolisib in Patients With Advanced/Metastatic Uveal Melanoma

NCT06717126

Conditions: Eye Diseases, Eye Neoplasms, Melanoma, +15 more
Locations: SSD Tumori Rari e Melanoma Viale Orazio Flacco Bari, Italy

IRCSS National Cancer Institute, "G.Pascale" Foundation Dip. CORP-S di Ricerca ed Assistenziale Cute, Melanoma lmmunologia Oncologica Sperimentale e Terapie Innovative Naples, Italy

IRCSS Istituto Oncologico Veneto UOS Oncologia 2 del Melanoma Ospedale Busonera Padova, Italy

IRCCS Istituto Clinico Humanitas Rozzano, Italy

View all 16 locations

View Trial Details

Active, Not Recruiting

Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract

NCT00582647

Conditions: Bile Duct Diseases, Bile Duct Neoplasms, Biliary Tract Diseases, +34 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Active, Not Recruiting

Triple Immune Checkpoint Inhibition for Advanced or Metastatic PD-(L)1 Refractory Merkel Cell Carcinoma

NCT06056895

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +16 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Neuroendocrine Tumors

Neuroendocrine Tumors trial results

Related conditions